Getinge AB (publ)
GETI-B.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$69.76B
Close$
$169.85
33.2% downside
Current Fair Value
33.2% downsideOvervalued by 33.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $69.76 Billion |
|---|---|
| Enterprise Value | $78.81 Billion |
| Dividend Yield | $4.75 (1.88%) |
| Earnings per Share | $8.29 |
| Beta | 0.83 |
| Outstanding Shares | 272,370,000 |
Return
| Return on Equity | 8.62% |
|---|---|
| Return on Assets | 4.65% |
| Return on Invested Capital | 9.78% |
Valuation & Multiples
| P/E Ratio | 25.76 |
|---|---|
| PEG | 42.58 |
| Price to Sales | 2.03 |
| Price to Book Ratio | 2.25 |
| Enterprise Value to Revenue | 2.31 |
| Enterprise Value to EBIT | 17.77 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 17, 2026
EPS Estimate
$2.15
Average shareholder expectationRevenue Estimate
$8.31 B
Average shareholder expectationNext Earnings Call
Expected Date
October 21, 2026
EPS Estimate
$2.49
Average shareholder expectationRevenue Estimate
$8.49 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Getinge AB (publ)
12,118 employees
CEO: Mattias Perjos Getinge AB (publ), established in Gothenburg, Sweden, in 1904, is a prominent global provider of advanced medical technology. The company specializes in delivering comprehensive products and integrated solutions tailored for operating ro...